Aurobindo Pharma | ARBP - Operating Expenses

Stock Price
1,210.90
Daily Change
-15.25 -1.24%
Monthly
0.29%
Yearly
1.60%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR70.37B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Cipla INR 60.98B 1.06B Dec/2025
Divis Laboratories Ltd INR 19.4B 1.47B Sep/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Hindustan Unilever INR 128.7B 2.87B Sep/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
UPL INR 106.63B 780M Dec/2025